Tiletamine Hcl; Zolazapam Hcl

523 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

523

Total Reports

115

Deaths Reported

2200.0%

Death Rate

Active Ingredients

Tiletamine Hcl; Zolazapam Hcl

Administration Routes

IntramuscularUnknownIntravenousSubcutaneousOtherOphthalmic

Species Affected

Dog 246

Cat 226

Unknown 33

Human 8

Pig 4

White tailed deer 2

Primate 2

Bear 1

Moose 1

Most Affected Breeds

Domestic Shorthair 112

Dog (unknown) 77

Unknown 45

Cat (unknown) 44

Cat (other) 29

Retriever - Labrador 23

Domestic Longhair 19

Shih Tzu 8

Boxer (German Boxer) 8

Domestic Mediumhair 7

Most Reported Reactions

INEFFECTIVE, ANESTHESIA 94

Death 67

Lack of efficacy - NOS 54

Cardiac arrest 41

INEFFECTIVE, SEDATION 35

Incorrect route of drug administration 35

Underdose 34

Lethargy (see also Central nervous system depression in 'Neurological') 32

Recovery prolonged 31

Vomiting 29

Death by euthanasia 27

Behavioural disorder NOS 27

Outcome Breakdown

Recovered/Normal

213 (42.4%)

Ongoing

109 (21.7%)

Died

70 (13.9%)

Outcome Unknown

64 (12.7%)

Euthanized

45 (9.0%)

Recovered with Sequela

1 (0.2%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.